A user reported a meaningful uptick in aerobic endurance starting around the third week of a subcutaneous MOTS-c cycle. They administered 5mg twice weekly over an eight-week period.
A user reported a meaningful uptick in aerobic endurance starting around the third week of a subcutaneous MOTS-c cycle. They administered 5mg twice weekly over an eight-week period.